Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Perspectives for leprosy control and elimination

Ignotti E, Steinmann P. FapUNIFESP (SciELO). Cadernos de Saúde Pública. 2020;
Download PDF
Publication

Thickened sural nerve in Hansen's disease.

Manchanda R, Dhar N, Kumar M, et al. QJM : monthly journal of the Association of Physicians. 2020;
Download PDF
Publication

Leprosy (Mycobacterium leprae)

Dupnik K. Elsevier Inc.. Infectious Diseases and Their Etiologic Agents. 2014;
Download PDF
Publication

Polymerase Chain Reaction [PCR] versus Slit Skin Smear in Diagnosis of Leprosy

Mostafa kamel N. Egypts Presidential Specialized Council for Education and Scientific Research. International Journal of Medical Arts. 2020;
Publication

Lighting up of m.leprae

(M.D.Pathology) SL. Valley International. Journal of Medical Science And clinical Research. 2019;
Download PDF
Publication

Dominant marker (inter-simple sequence repeat-polymerase chain reaction) versus codominant marker (RLEP-polymerase chain reaction) for laboratory diagnosis of leprosy: A comparative evaluation.

Mohanty P, Bansal AK, Naaz F, et al. International journal of mycobacteriology. 2020; 9 (1) : 18-23.
Download PDF
Publication

Barriers and facilitators related to leprosy detection in Costa Rica

Chavarría AR, Hernández GS, Aguirre AE. Acta méd costarric. 2020; 62 (2) : 65-71.
Download PDF
Publication

A Clinical and Histopathological Correlation among Leprosy Patients (in this Post Elimination Era) Attending Tertiary Referral Centre

Thombare MM, Kote R, Gugle A, et al. Informatics Publishing Limited. MVP Journal of Medical Sciences. 2019; 6 (2) : 103-108.
Download PDF
Publication

Ultra-sensitive detection of Mycobacterium leprae: DNA extraction and PCR assays.

Manta F, Leal-Calvo T, Moreira S, et al. PLoS neglected tropical diseases. 2020; 14 (5) : e0008325.
Publication

Leprosy in the twenty-first century: a microbiological, clinical, and epidemiological study in northwestern Spain.

Barbeito-Castiñeiras G, Mejuto B, Nieto A, et al. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 2020;

Pagination

  • Previous page ‹‹
  • Page 85
  • Next page ››
Subscribe to Diagnosis

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD